MONTRÉAL, Aug. 21, 2014 /CNW Telbec/ - Dr. John S. Sampalis is founder and CEO of JSS Medical Research and one of the world's leading clinical epidemiologists. Dr. Sampalis is nominated as a finalist in this year's 2014 EY Entrepreneur Of The Year in the Québec Health Sciences category.
The Ernst & Young Entrepreneur Of The Year program is in its 21st year of honouring the most successful entrepreneurs from all areas of business including, among others, manufacturing, media and entertainment, real estate/construction, technology and communication and health sciences.
"I am thrilled and honored to be a finalist for this prestigious award. The nomination is testimony to the continued growth of JSS Medical Research and our recognition as a leading CRO not only in Canada but also globally. This could not have been possible without the support and hard work of my team of outstanding and skilled professionals.
I am grateful for the opportunity to work with and represent everyone working at JSS Medical Research, in this competition," said Dr. John S. Sampalis, Chief Executive Officer at JSS Medical Research.
The Québec winners will be announced at a gala on October 23, 2014. The overall Québec winner will represent the region at the national gala held in Toronto on November 25, 2014.
About EY Entrepreneur Of The Year
EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential, and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 145 cities in more than 60 countries.
For more information, visit www.ey.com/ca/EOY.
About JSS Medical Research
JSS Medical Research is a full-service Contract Research Organization with its corporate office in Montréal, Canada and a regional office in Bogota, Colombia. The company offers comprehensive clinical trial management services, from study design to publication of results, in Phase I-IV trials across a broad range of therapeutic areas. Biotechnology companies rely on the company's knowledgeable project teams, and its customer-centric and flexible approach to successfully conduct their critical early phase trials, while pharmaceutical companies can leverage its niche post-marketing service offerings. With science and clinical epidemiological expertise at its core, JSS Medical Research is a leader in Post-Approval Clinical Epidemiology Studies (PACES) including Post-Marketing Observational Studies, Health Outcomes Research and Health Economics. Currently JSS Medical Research is conducting research studies in over 20 countries around the world for its clients which include the top 25 global pharmaceutical companies and a biotechnology companies, worldwide.
For more information, visit www.jssresearch.com.
Image with caption: "Dr. John S. Sampalis (CNW Group/JSS Medical Research Inc.)". Image available at: http://photos.newswire.ca/images/download/20140821_C2202_PHOTO_EN_5024.jpg
SOURCE: JSS Medical Research Inc.
For further information: Joanne Watson, M.Sc., Chief Business Officer, 514 934 6116 ext. 260, firstname.lastname@example.org; Sanjay Machado, M.D., Executive Director, Global Business Operations, 514 934 6116 ext. 224, email@example.com